Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Gelatinase inhibitors prepared by Ono

March 11, 1997

MMP inhibitors from Ono

March 10, 1997

U.S. patent covers Immunex's TNFR

March 7, 1997

IVAX receives approval for generic NSAID

March 6, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Protein kinase inhibitors reported by Roche

March 5, 1997

Teva's Tolmetin approved

March 4, 1997

Celgene receives patent for selective cytokine-inhibitory drugs

March 4, 1997

Faulding receives approval for etodolac tablets

March 4, 1997

Zeneca reports cell adhesion inhibitors

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...